This is the second installment in a specialized series of guest contributions from industry veteran Michael Gay. Throughout his extensive career in property and casualty insurance, Gay has observed firsthand how technological advancements in underwriting tools can sometimes create a false sense of security for insurance professionals and their clients alike. Commercial replacement cost estimating […]
For decades, the pharmaceutical industry has relied heavily on animal models to test the safety and efficacy of emerging therapeutics. Yet, fundamental biological differences between species mean that a drug performing successfully in a mouse or a larger animal frequently fails when translated to human clinical trials. Most pharmaceutical candidates still ultimately fail during development, […]